Recalls / Active ingredient / Imatinib Mesylate
Imatinib Mesylate
3 FDA drug recalls involving the active ingredient “Imatinib Mesylate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-02-17 | Class II | Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional | Dr. Reddy's Laboratories, Inc. |
| 2020-12-08 | Class II | Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, D | Shilpa Medicare Limited |
| 2020-12-08 | Class II | Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, D | Shilpa Medicare Limited |